share_log

Kezar Life Sciences Q4 EPS $(0.44) Misses $(0.38) Estimate

Moomoo 24/7 ·  Mar 14 16:04

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.38) by 15.79 percent. This is a 76 percent decrease over losses of $(0.25) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment